Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Nanocatalytic Immunotherapy Targeting Tumor-Resident Intracellular Bacteria for Triple-Negative Breast Cancer Treatment and Metastasis Suppression.

Created on 01 Nov 2026

Authors

Xiaojing Leng, Tao Jiang, Zhao Guo, Zhimin Zhang, Yihan Chen, Pan Li, Min Ge, Han Lin, Liang Zhang

Published in

Advanced science (Weinheim, Baden-Wurttemberg, Germany). Oct 31, 2026. Epub Oct 31, 2026.

Abstract

Tumor-resident intracellular bacteria (TRIB) are prevalent within triple-negative breast cancer (TNBC). As integral components of the tumor pathological microenvironment, TRIB accelerate TNBC development by regulating cell proliferation, metabolism and immunosuppression. They also enhance the resistance of circulating tumor cells to mechanical stress through cytoskeletal rearrangement, boosting tumor metastasis and hindering clinical therapy. This work develops an advanced TRIB-targeted therapeutic strategy to block TNBC progression by eliminating tumor cells and intracellular bacteria, remodeling tumor immunity and suppressing metastatic colonization. We fabricate cancer cell membrane-modified narrow-bandgap FeSe2 nanosheets for enhanced ultrasound-triggered reactive oxygen species production and image-guided precise treatment. Such nanoplatforms utilize endogenous H2O2 and GSH to amplify chemodynamic effects, induce severe oxidative stress and ferroptosis in tumor cells. Combined damage-associated and pathogen-associated molecular patterns efficiently activate dendritic cells and initiate robust antigen-specific T-cell immune responses. This study provides an alternative and promising strategy for the treatment of clinically metastatic breast cancer through intratumoral microbiota intervention.

PMID:
42966887
Bibliographic data and abstract were imported from PubMed on 01 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement